The Investor Relations Page provides members of the investment community with easy access to the most updated
information regarding Regeneron Pharmaceuticals, Inc. Regeneron has a growing portfolio of product candidates in various stages
of clinical testing required for product approval. The Company is developing new product candidates in diverse fields such as cancer,
eye diseases, and certain inflammatory diseases.
Contact Us
If you are a member of the investment community with a question about Regeneron, please call our Investor Relations Line at (914) 345-7400.
For an email response to your Regeneron investment questions, please contact us at investor.relations@regeneron.com
Stock Transfer Agent
Inquiries relating to stock transfer or lost certificates or notices of changes of address should be directed to
our Transfer Agent:
American Stock Transfer & Trust
59 Maiden Lane
Plaza Level
New York, NY 10038
(800) 937 5449
web site
59 Maiden Lane
Plaza Level
New York, NY 10038
(800) 937 5449
web site
Corporate Governance
Regeneron is committed to conducting its business in accordance with applicable laws, rules and regulations and the highest standards
of business ethics, and to full and accurate financial disclosure in compliance with applicable law.